Skip to main content

Healthcare Analytics Market Size 2021 | Is projected reach USD 80.21 billion by 2026

Pune, India, March 31, 2021 (GLOBE NEWSWIRE) — According to the report, Healthcare Analytics market size is projected reach USD 80.21 billion by 2026. Healthcare analytics market was valued at USD 11.59 billion in 2018. The advancement in technologies along with growing venture capital funding will aid the market in the region.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/healthcare-analytics-market-102641

Cerner Corporation, an American health information technology solutions and services company launched a trailblazing platform, project Apollo. The new cognitive platform will provide computing resources to its healthcare users. The cloud-based automation platform is built on AWS infrastructure for speedy innovations to eliminate manual steps that cast obstructions for new advancement. The launch of the platform will have a positive impact on the healthcare analytics market share owing to the its next-gen technology for healthcare clients.

The emergence of big data in healthcare can be a vital factor in boosting the healthcare analytics market revenue during the forecast period. Moreover, the rising venture capital investments by major companies will contribute positively to the healthcare analytics market trends in the forthcoming years. For instance, Cigna Ventures, a venture capital fund company invested $29.5M in Arcadia, a healthcare data and software company. The new development of Arcadia will help enhance patient care and adoption of value-based care models along with access to resources and tools to health care professionals

               
The launch of the platform will have a positive impact on the healthcare analytics market share owing to the its next-gen technology for healthcare clients. Moreover, the deal between the Cerner and Geisinger will bolster healthy growth of the market during the forecast period.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/healthcare-analytics-market-102641

Big Data is Transforming Healthcare Analytics Market

Moreover, the adoption of electronic health records and presence of eminent players in the region. Europe is expected to hold a major share in the global market owing to the rising emphasis on healthcare and favorable reimbursement policies.

Asia Pacific is predicted to witness steady growth due to the growing awareness and adoption of healthcare analytics. Moreover, the developing healthcare infrastructure and high spending on healthcare will contribute positively to the market in Asia Pacific.

INDUSTRY DEVELOPMENT:

  • August 2019 Clarivate Analytics launched Cortellis Digital Health Intelligence solution. The solution is first-of-its kind covering global digital health ecosystem. This will help the drug, device, and technology developers to fully use the digital technology.
  • February 2018 Infor, a leader in providing industry-specific cloud applications launched Infor Healthcare Enterprise Analytics. This solution will provide healthcare organizations to transform complex data into a comprehensive picture of patient and population health

Quick Buy –  Healthcare Analytics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102641

  • IBM Corporation (IBM Watson)
  • Flatiron Healt
  • Linguamatics
  • Allscripts Healthcare
  • Epic Systems Corporation
  • Health Catalyst
  • Inovalon

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/healthcare-analytics-market-102641

Global Healthcare Analytics Market Segmentations:

By Product

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Application

  • Financial Analytics
  • Population Health Analytics
  • Clinical Analytics
  • Operations and Administrative analytics

By End User 

  • Payers
  • Providers
  • Others

By Geography

•              North America (U.S. and Canada)

•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

•              Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

•              Latin America (Brazil, Mexico, and Rest of Latin America)

•              Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/healthcare-analytics-market-102641

Have a Look at Related Reports:

Prothrombin Complex Concentrate (PCC) Market Size, Share & COVID-19 Impact Analysis, By Product (3-factor PCC and 4-factor PCC), By Application (Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency), By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics and Others), and Regional Forecast, 2020-2027

Robotic Surgical Procedures Market Size, Share and Industry Analysis By Product Type (Gynecology, Urology, General Surgery, Orthopedics and Others), and Regional Forecast 2018-2025

Transrectal Ultrasound Market Size, Share and Industry Analysis By Product (Systems, Transducers), Type (Cart/Trolley Based, Portable), Application (Diagnostic, Image-guided Treatment), End User (Diagnostic Laboratories, Hospitals) and Regional Forecast, 2018 – 2025

Breast Cancer Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, and Immunotherapy), By Cancer Type (Hormone Receptor, and HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027

Orthobiologics Market Size, Share and Industry Analysis by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), By Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), By End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics), and Regional Forecast 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/Healthcare Analytics-market-9421

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.